- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | TRANSCENTA-B (06628): POSTPONEMENT OF ANNUAL GENERAL MEETING AND CHANGE OF PERIODS OF CLOSURE OF REGISTER OF MEMBERS | - | HKEx | ||
| 28.04. | TRANSCENTA-B (06628): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED HOLDERS | - | HKEx | ||
| TRANSCENTA Aktie jetzt für 0€ handeln | |||||
| 28.04. | TRANSCENTA-B (06628): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS | - | HKEx | ||
| 28.04. | TRANSCENTA-B (06628): 2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | - | HKEx | ||
| 28.04. | TRANSCENTA-B (06628): 2025 ANNUAL REPORT | - | HKEx | ||
| 23.04. | Transcenta Therapeutics Presents New Data for its Novel LIV1-Targeting ADC TST013 Demonstrating Potent Anti-Tumor Activity in PDX Models of Prostate Cancer and ER Positive /HER2 Negative Breast Cancer | 2 | GlobeNewswire (USA) | ||
| 23.04. | Transcenta Holding LIV1 Antibody-Drug Conjugate Preclinical Data Demonstrate Strong Anti-tumor Activity | 1 | AASTOCKS | ||
| 23.04. | TRANSCENTA-B (06628): VOLUNTARY ANNOUNCEMENT-TRANSCENTA PRESENTS NEW DATA FOR ITS NOVEL LIV1-TARGETING ADC TST013 DEMONSTRATING POTENT ANTI-TUMOR ACTIVITY ... | - | HKEx | ||
| 08.04. | TRANSCENTA-B (06628): (1) CHANGE OF STOCK SHORT NAME; AND (2) CHANGE OF COMPANY LOGO | 1 | HKEx | ||
| 31.03. | TRANSCENTA-B (06628): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025 | 1 | HKEx | ||
| 30.03. | Transcenta Therapeutics Appoints Dr. Christopher Hwang as Head of Global Partnerships for HiCB Platform | 2 | GlobeNewswire (USA) | ||
| 18.03. | TRANSCENTA-B (06628): DATE OF BOARD MEETING | 1 | HKEx | ||
| 24.02. | TRANSCENTA-B (06628): VOLUNTARY ANNOUNCEMENT-TRANSCENTA TO PRESENT AT THE 36TH ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE | 2 | HKEx | ||
| 22.01. | TRANSCENTA-B (06628): UPDATE ON MEASURES AND ACTIONS TAKEN IN RESOLVING THE DISCLAIMER OF OPINION IN THE ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, ... | - | HKEx | ||
| 29.12.25 | EirGenix Licenses Transcenta's HiCB Platform to Improve Process Efficiency | 1 | Contract Pharma | ||
| 29.12.25 | TRANSCENTA-B (06628): GRANT OF AWARD SHARES PURSUANT TO THE SHARE INCENTIVE SCHEME | 1 | HKEx | ||
| 29.12.25 | Transcenta Collaborates With EirGenix To License HiCB Platform | - | RTTNews | ||
| 29.12.25 | Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive Licensing Agreement to Advance Integrated Continuous Biomanufacturing and Expand Global Access to Affordable Biologics | 270 | GlobeNewswire (Europe) | PRINCETON, N.J. and HANGZHOU, China, Dec. 28, 2025 (GLOBE NEWSWIRE) -- Transcenta Holding Limited (HKEX: 06628) ("Transcenta Therapeutics"), a global clinical stage biopharmaceutical company with... ► Artikel lesen | |
| 29.12.25 | TRANSCENTA-B (06628): VOLUNTARY ANNOUNCEMENT-TRANSCENTA ANNOUNCES STRATEGIC COLLABORATION AND NON-EXCLUSIVE LICENSING AGREEMENT TO ADVANCE INTEGRATED ... | 1 | HKEx | ||
| 05.12.25 | Transcenta Therapeutics Presents Updated Efficacy Data from the Phase I/II Transtar102 Trial of Osemitamab plus Nivolumab and CAPOX in First-Line G/GEJ Cancer at ESMO Asia | 79 | GlobeNewswire (Europe) | PRINCETON, N.J. and SUZHOU, China, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Transcenta Holding Limited (HKEX: 06628) ("Transcenta Therapeutics"), a global clinical stage biopharmaceutical company with fully-integrated... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| QIAGEN | 28,660 | +0,24 % | Qiagen erhöht Dividende und stellt weitere Aktienrückkäufe in Aussicht | DJ Qiagen erhöht Dividende und stellt weitere Aktienrückkäufe in Aussicht
DOW JONES--Die Aktionäre von Qiagen können sich über eine höhere Dividende freuen. Wie es in der Einladung zur Hauptversammlung... ► Artikel lesen | |
| GEOVAX LABS | 3,240 | +163,41 % | Morning Market Movers: Sunshine Biopharma, GeoVax Labs, Huachen AI Parking Management Technology, LiveRamp See Big Swings | BEIJING (dpa-AFX) - At 8:15 a.m. ET on Monday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| DESIGN THERAPEUTICS | 11,460 | -20,25 % | Design Therapeutics, Inc.: Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in Friedreich Ataxia | DT-216P2 demonstrated dose-dependent improvement in multiple clinical measures and increases in endogenous frataxin mRNA and protein after four weeks of intravenous dosing DT-216P2 generally well-tolerated... ► Artikel lesen | |
| VIRAX BIOLABS GROUP | 0,517 | +236,81 % | RedChip Companies, Inc.: Avalon Advanced Materials and Virax Biolabs Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | ORLANDO, FL / ACCESS Newswire / May 15, 2026 / RedChip Companies will air interviews with Avalon Advanced Materials Inc. (OTCQB:AVLNF)(TSX:AVL) and Virax Biolabs Group Limited (Nasdaq:VRAX) on the RedChip... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 2,865 | -2,22 % | Recursion Pharmaceuticals (RXRX): 10 Unrivaled Penny Stocks to Buy Now | ||
| PRAXIS PRECISION MEDICINES | 323,87 | -5,46 % | Praxis Precision Medicines, Inc. - 8-K, Current Report | ||
| CG ONCOLOGY | 66,02 | -1,36 % | CG Oncology Inc.: CG Oncology Reports Positive First Results from CORE-008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients | - High CR rates at any time observed in the CIS-containing population with 85.7% and 92.3% in the ITT population and Efficacy Evaluable population, respectively - High-Grade - EFS in the overall intention-to-treat... ► Artikel lesen | |
| BIONTECH | 76,15 | -3,30 % | BERENBERG stuft Biontech auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Biontech von 155 auf 140 US-Dollar gesenkt, aber die Einstufung auf "Buy" belassen. Mit dem neuen Kursziel trage er dem zunehmenden... ► Artikel lesen | |
| TANGO THERAPEUTICS | 20,670 | +0,54 % | Tango Therapeutics, Inc.: Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights | First clinical data from PRMT5/RAS(ON) combination trial to be presented in 2026 Cash position of $380 million as of March 31, 2026, with runway into 2028 beyond anticipated key data inflection points... ► Artikel lesen | |
| REGENERON PHARMACEUTICALS | 534,00 | -11,16 % | Regeneron Pharmaceuticals-Aktie -12%: Unterschätzen alle diesen Pharmakonzern? | Mit einem Kurssturz von -12% hält die Regeneron Pharmaceuticals-Aktie am Montagmorgen fest die rote Laterne im S&P 500-Index in der Hand. Warum bricht der Kurs des US-Pharmakonzerns zum Wochenbeginn... ► Artikel lesen | |
| QUINCE THERAPEUTICS | 1,185 | +3,04 % | Quince announces acquisition of Orphai and up to $187M private placement to advance pulmonary pipeline | ||
| EVOTEC | 4,696 | -0,09 % | KURSRUTSCH bei Nel ASA und Evotec! KURSCHANCE bei HPQ Silicon! | Steht die Aktie von HPQ Silicon vor einer Neubewertung? Dafür gibt es jedenfalls gute Gründe. Die Hochleistungsbatterien haben erneut überzeugt. Damit könnte für Anwendungen in Drohnen, Verteidigung... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 16,330 | -3,20 % | H.C. Wainwright Reduced its Price Goal on Summit Therapeutics Inc. (SMMT) | ||
| ARCUTIS BIOTHERAPEUTICS | 20,690 | -2,96 % | Arcutis Q1 2026: Umsatz steigt um 65 %, doch Expansionskosten führen zu höheren Verlusten | ||
| VERA THERAPEUTICS | 34,760 | -6,86 % | Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer | BRISBANE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a biotechnology company focused on developing and commercializing transformative treatments for patients... ► Artikel lesen |
Das Unternehmen TRANSCENTA HOLDING LTD kann der Branche Biotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TRANSCENTA HOLDING LTD finden Sie auf Wallstreet Online.